|Bid||42.22 x 800|
|Ask||104.71 x 1000|
|Day's range||100.92 - 104.93|
|52-week range||31.30 - 122.85|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||N/A|
|Earnings date||12 Nov 2020|
|Forward dividend & yield||N/A (N/A)|
|1y target est||127.56|
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Turning Point Therapeutics (TPTX) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.
Turning Point Therapeutics (TPTX) delivered earnings and revenue surprises of 14.58% and -100.00%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?